Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Picard Medical, Inc.

Stage 1 · Basing · week 2

As of Oct 22, 2026, Picard Medical is in Stage 1, the basing phase, now in week 2 (since Oct 13, 2026). It closed at $7.37, 98.9% below its 52-week high and below its 200-day average, which is falling.

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. More about the company

$7.37
-22.99% today
$17.2M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Basing, not in an uptrend yet

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is PMI early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2025-08-29 → 2026-10-22
S? 42w
S4 17w
2025-08-292026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 42w → S4 17w → S1 1w current
Total tracked: 60 weeks across 3 stage runs.

PMI among Medical Devices130th of 141 by relative strength

All 141 →
Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#StockStageRS1M
1TXGStage 2 · wk 4899−7.8%
2RCELStage 2 · wk 1398+40.8%
3BFLYStage 2 · wk 2698−26.0%
4HAEStage 2 · wk 1796+8.7%
5GKOSStage 2 · wk 2596+15.1%
6AXGNStage 3 · wk 295−15.3%
7NEOGStage 2 · wk 1495−11.7%
8BVSStage 2 · wk 1595+10.5%
…130PMIStage 1 · wk 23+62.0%
vs 52W High
-98.9%
$3.03 lo$660.00 hi
98.9% below 52W high
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 2
1w13w26w
Week 2, early base
How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.
vs 200 DMA
-75.4%
200 DMA: $29.93 · sloping down
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.16x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↑ ⇈
Short-term trend rising strongly, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+62.0%
3M
+67.5%
6M
-82.5%
YTD
-91.9%
1Y
-98.8%
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-10-22S1
Wk 2 · Vol 0.16x
2026-10-21S1
Wk 2 · Vol 0.20x
2026-10-20S1
Wk 2 · Vol 0.50x
2026-10-19S1
Wk 1 · Vol 0.37x
2026-10-16S1
Wk 1 · Vol 0.81x
2026-10-15S1
Wk 1 · Vol 0.76x
2026-10-14S1
Wk 1 · Vol 0.08x
2026-10-13S14→1
Wk 1 · Vol 0.61x
2026-10-12S4
Wk 17 · Vol 0.36x
2026-10-09S4
Wk 17 · Vol 0.16x
2026-10-08S4
Wk 16 · Vol 0.13x
2026-10-07S4
Wk 16 · Vol 0.42x
Moving averages & range
50 DMA
$6.70
200 DMA
$29.93
52W High
$660.00
52W Low
$3.03
5D Low
$7.37
Resistance levels (recent highs)
20d High
$15.45
60d High
$15.45
120d High
$17.60
250d High
$265.50
Next resistance
+109.6%
to 20d High
Dividend Yield
0.00%
P/B 8.8

Picard Medical: quick answers

What stage is Picard Medical in?

As of Oct 22, 2026, Picard Medical (PMI) is in Stage 1, the basing phase. It entered Stage 1 on Oct 13, 2026 and is in week 2. What the four stages mean

Is Picard Medical in an uptrend?

Not yet. Picard Medical is in Stage 1, a base that can come before an uptrend. It trades 75.4% below its 200-day average, which is falling.

How far is Picard Medical from its 52-week high?

Picard Medical closed at $7.37 on Oct 22, 2026, 98.9% below its 52-week high of $660.00. Its 52-week low is $3.03.

How has Picard Medical performed over the past year?

As of Oct 22, 2026, Picard Medical is down 98.8% over the past year and down 91.9% so far in 2026.

Which sector and industry is Picard Medical in?

Picard Medical is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.